Printer Friendly

INTERNATIONAL MUREX TECHNOLOGIES CORPORATION CLOSES EURO-EQUITY OPTION FOR NEW COMMON SHARES

 INTERNATIONAL MUREX TECHNOLOGIES CORPORATION CLOSES
 EURO-EQUITY OPTION FOR NEW COMMON SHARES
 TORONTO, Jan. 14 /PRNewswire/ -- International Murex Technologies Corporation (AMEX: MXX; TSE) announced today that it has closed on the 890,000 share option at U.S. $11.25 per share, granted in connection with the previously completed financing on Dec. 20, 1991.
 This brings the total funds raised by MXX in the Euro-Equity offering announced on Nov. 15, 1991, to U.S. $45 million and the number of common shares outstanding to approximately 14.9 million.
 The new securities, issued in Europe and elsewhere outside of North America in this offering, are subject to Securities and Exchange Commission (SEC) and Ontario Securities Commission (OSC) regulations which provide that the 890,000 common shares may not be traded in North America until Feb. 24.
 The net proceeds of the U.S. $45 million Euro-Equity offering will be used by MXX to continue its ongoing acquisition program and for general working capital requirements.
 Toronto-based MXX is an international medical diagnostic systems company dedicated to the development, manufacture and global marketing of cost-effective diagnostic tests for infectious diseases and products for the blood banking industry.
 -0- 1/14/92
 /CONTACT: C. Robert Cusick, president and chief executive officer, 416-408-4682, or Marcia M. Young, 800-688-1332, both of International Murex Technologies/
 (MXX) CO: International Murex Technologies Corporation ST: Ontario IN: MTC SU:


BR-BN -- AT029 -- 9716 01/14/92 16:44 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 14, 1992
Words:237
Previous Article:HARRIS NAMES DAVID E. HALLEY VICE PRESIDENT-GENERAL MANAGER OF AIR TRAFFIC CONTROL SYSTEMS DIVISION
Next Article:OLYMPIC FINANCIAL FILES REGISTRATION STATEMENT FOR INITIAL PUBLIC OFFERING OF 1,600,000 SHARES
Topics:


Related Articles
INTERNATIONAL MUREX REPORTS NOTIFICATION OF 13-D FILING
INTERNATIONAL MUREX TECHNOLOGIES ANNOUNCES EQUITY OFFERING
INTERNATIONAL MUREX TECHNOLOGIES CORPORATION ANNOUNCES THIRD QUARTER RESULTS
INTERNATIONAL MUREX TECHNOLOGIES ANNOUNCES PRICING OF EURO-EQUITY FINANCING
INTERNATIONAL MUREX TECHNOLOGIES CORPORATION ANNOUNCES EXERCISE OF OPTION AND INCLUSION IN TSE 300 COMPOSITE INDEX
INTERNATIONAL MUREX TECHNOLOGIES CORPORATION ANNOUNCES COMPLETION OF THE PURCHASE OF WELLCOME DIAGNOSTICS
INTERNATIONAL MUREX TECHNOLOGIES CORPORATION ANNOUNCES DIVESTITURE OF ITS BLOOD TYPING AND GROUPING REAGENT BUSINESS
BRITISH COURT RULES ON HEPATITIS C PATENT; MUREX CONTINUES TO SELL ANTI-HCV PRODUCTS
INTERNATIONAL MUREX PROMOTES J. DAVID THOLEN TO CHIEF EXECUTIVE OFFICER
International Murex Reports First Quarter Earnings of $0.10 Per Share

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters